Le Matin, Fre - First it was Breitling whose hot air balloon world tour was celebrated on a stamp in 1999 and now it's Rolex's turn to smile at the additional free publicity from having its watch appear on Swiss postage stamps. Roger Federer's new stamp shows the tennis champion holding his Wimbledon trophy - with his Rolex in plain view. Le Matin talked to watchmakers as the [annual watch fair](http://www.baselworld.com/go/id/ss/lan (continue reading)→
This is a printed article from GenevaLunch.com. Visit the site online at http://www.genevalunch.com.
Basel, Switzerland
Federer's watch gives Rolex an extra smile as watch fair opens in Basel
Novartis sells Gerber to Nestlé
Le Temps, Fre - Novartis has announced the sale of Gerber, its line of baby foods, to Nestlé, for SFr6.7 million in cash. The sale makes Nestlé the world's number one baby food company. The line is expected to create turnover of SFr10 billion.
Roger Federer stamp
Coop has a healthy year
romandie/ats, Fre - Coop, Switzerland's second-largest supermarket chain, reported Tuesday that profits and sales were both up comfortably and that it increased market share. Its turnover in the retail market in 2006 was SFr14.7 billion, up 4.6% over the previous year, with an overall increase of 4.7% to SFr15.6 billion for the group. The company invested SFr270 million to lower its prices by 1.8% in order to offer the same prices as Migros, its main competitor and the market leader. (continue reading)→
Novartis says no to Daniel Vasella's golden handshake
GenevaLunch and sources - Daniel Vasella, CEO of pharmaceutical giant Novartis, will not have a golden handshake written into his contract after the current one expires in 2009. The change is a victory for those shareholders who have been battling the company in recent years over what they see as excessive remuneration packages for top managers.
Vasella shares the top payment slot for managers in Switzerland with banker Marcel Ospel of UBS. How much he earns depends on who you ask, Le Temps points out: according to the Novartis annual report he earned SFr21 million in 2006, but according to the Ethos Foundation he earned SFr44m. (continue reading)→